Search Results

There are 4209 results for: content related to: YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine

  1. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C

    Journal of Viral Hepatitis

    Volume 14, Issue 11, November 2007, Pages: 767–774, X. P. Pan, L. J. Li, W. B. Du, M. W. Li, H. C. Cao and J. F. Sheng

    Article first published online : 15 APR 2007, DOI: 10.1111/j.1365-2893.2007.00869.x

  2. Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 398–404, D. N. Moskovitz, C. Osiowy, E. Giles, G. Tomlinson and E. J. Heathcote

    Article first published online : 26 APR 2005, DOI: 10.1111/j.1365-2893.2005.00613.x

  3. Treatment of chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 333–345, P. Marcellin, T. Asselah and N. Boyer

    Article first published online : 28 JUN 2005, DOI: 10.1111/j.1365-2893.2005.00599.x

  4. Two years of lamivudine therapy in anti-HBe-positive patients with chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 8, Issue 4, July 2001, Pages: 270–275, M. Buti, M. Cotrina, R. Jardi, E. Cruz De Castro, F. Rodriguez-Frias, F. Sánchez-Avila, R. Esteban and J. Guardia

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1365-2893.2001.00296.x

  5. Application of allele-specific RNAi in hepatitis B virus lamivudine resistance

    Journal of Viral Hepatitis

    Volume 18, Issue 10, October 2011, Pages: e491–e498, X. Teng, J.-Y. Liu, D. Li, Y. Fang, X.-Y. Wang, Y.-X. Ma, S.-J. Chen, Y.-X. Zhao, W.-Z. Xu and H.-X. Gu

    Article first published online : 7 JUL 2011, DOI: 10.1111/j.1365-2893.2011.01483.x

  6. Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients

    Journal of Viral Hepatitis

    Volume 10, Issue 5, September 2003, Pages: 367–382, S. S. Gandhe, M. S. Chadha, A. M. Walimbe and V. A. Arankalle

    Article first published online : 8 SEP 2003, DOI: 10.1046/j.1365-2893.2003.00445.x

  7. Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 3, May 2005, Pages: 262–268, C. Yurdaydin, H. Bozkaya, H. Çetinkaya, T. Şahin, D. Karaoğuz, M. Törüner, Ö. Erkan, A. O. Heper, E. Erden, A. M. Bozdayi and Ö. Uzunalimoğlu

    Article first published online : 20 JAN 2005, DOI: 10.1111/j.1365-2893.2005.00566.x

  8. A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy

    Journal of Viral Hepatitis

    Volume 19, Issue 8, August 2012, Pages: 581–593, F.-Q. Yang, Y.-Y. Yu, G.-Q. Wang, J. Chen, J.-H. Li, Y.-Q. Li, G.-R. Rao, G.-Y. Mo, X.-R. Luo and G.-M. Chen

    Article first published online : 26 FEB 2012, DOI: 10.1111/j.1365-2893.2012.01589.x

  9. Occult hepatitis B virus infection: a covert operation

    Journal of Viral Hepatitis

    Volume 17, Issue 1, January 2010, Pages: 1–15, F. B. Hollinger and G. Sood

    Article first published online : 9 DEC 2009, DOI: 10.1111/j.1365-2893.2009.01245.x

    Corrected by:

    Corrigendum

    Vol. 17, Issue 8, 600, Article first published online: 8 JUL 2010

  10. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users

    Journal of Viral Hepatitis

    Volume 13, Issue 8, August 2006, Pages: 560–570, C. Mathei, Z. Shkedy, B. Denis, C. Kabali, M. Aerts, G. Molenberghs, P. Van Damme and F. Buntinx

    Article first published online : 26 APR 2006, DOI: 10.1111/j.1365-2893.2006.00725.x

  11. Methamphetamine enhances Hepatitis C virus replication in human hepatocytes

    Journal of Viral Hepatitis

    Volume 15, Issue 4, April 2008, Pages: 261–270, L. Ye, J. S. Peng, X. Wang, Y. J. Wang, G. X. Luo and W. Z. Ho

    Article first published online : 9 DEC 2007, DOI: 10.1111/j.1365-2893.2007.00940.x

  12. Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 364–372, A. A. van der Eijk, B. E. Hansen, H. G. M. Niesters, H. L. A. Janssen, M. van de Ende, S. W. Schalm and R. A. de Man

    Article first published online : 22 APR 2005, DOI: 10.1111/j.1365-2893.2005.00620.x

  13. Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy

    Journal of Viral Hepatitis

    Volume 8, Issue 2, March 2001, Pages: 120–131, F. Querenghi, Qiang Yu, G. Billaud, G. Maertens, C. Trépo and F. Zoulim

    Article first published online : 15 DEC 2003, DOI: 10.1046/j.1365-2893.2001.00265.x

  14. Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model

    Journal of Viral Hepatitis

    Volume 9, Issue 2, March 2002, Pages: 114–122, S. Deuffic-Burban, T. Poynard and A.-J. Valleron

    Article first published online : 8 APR 2002, DOI: 10.1046/j.1365-2893.2002.00340.x

  15. Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection

    Journal of Viral Hepatitis

    Volume 9, Issue 1, January 2002, Pages: 18–28, T. Lancaster, E. Sanders, J. M. L. Christie, C. Brooks, S. Green and W. M. C. Rosenberg

    Article first published online : 11 JAN 2002, DOI: 10.1046/j.1365-2893.2002.00330.x

  16. Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe

    Journal of Viral Hepatitis

    Volume 8, Issue 3, May 2001, Pages: 206–216, G. Fattovich, M. L. Ribero, M. Pantalena, G. Diodati, P. Almasio, F. Nevens, F. Tremolada, F. Degos, J. Rai, A. Solinas, D. Mura, A. Tocco, I. Zagni, F. Fabris, L. Lomonaco, F. Noventa, G. Realdi, S. W. Schalm, A. Tagger and the Eurohep Study Group on Viral Hepatitis

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1365-2893.2001.00291.x

  17. siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations

    Journal of Viral Hepatitis

    Volume 13, Issue 11, November 2006, Pages: 756–761, Masayoshi Konishi, Catherine H. Wu, Masahiko Kaito, Kazuhiko Hayashi, Shozo Watanabe, Yukihiko Adachi and George Y. Wu

    Article first published online : 6 JUL 2006, DOI: 10.1111/j.1365-2893.2006.00752.x

  18. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication

    Journal of Viral Hepatitis

    Volume 13, Issue 3, March 2006, Pages: 158–165, J. Yang, X. C. Bo, X. R. Ding, J. M. Dai, M. L. Zhang, X. H. Wang and S. Q. Wang

    Article first published online : 29 SEP 2005, DOI: 10.1111/j.1365-2893.2005.00666.x

  19. A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization

    Journal of Viral Hepatitis

    Volume 8, Issue 5, September 2001, Pages: 331–340, M. Korenaga, K. Hino, Y. Katoh, Y. Yamaguchi, M. Okuda, K. Yoshioka and K. Okita

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1365-2893.2001.00305.x

  20. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

    Journal of Viral Hepatitis

    Volume 11, Issue 2, March 2004, Pages: 97–107, D. Lavanchy

    Article first published online : 20 FEB 2004, DOI: 10.1046/j.1365-2893.2003.00487.x